Catalyst Wire Dossier Catalyst Wire Dossier

Mapisal

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mapisal, covering 2013-10-22 to 2013-10-22. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Open-label Phase III Trial of Mapisal® Versus an Urea Hand-foot Cream as Prophylaxis for Capecitabine-induced Hand-foot Syndrome in Patients With Gastrointestinal Tumors or Breast Cancer

See pricing